ACR 2021 - Physician's Weekly


ACR 2021

ACR: A New Xanthine Oxidase Inhibitor for Gout on the Horizon

Tigulixostat was successfully tested in patients with gout and hyperuricemia for its serum urate-lowering capacity. The drug was overall well tolerated and without particular safety signals. These results support dose finding...

ACR: Statin Use in RA: Benefits Outweigh Diabetes Risk

New data on the advantages and disadvantages of statins for patients with rheumatoid arthritis showed significant reductions in cardiovascular and all-cause mortality but an increased risk for type 2 diabetes mellitus. Not all...



For latest news and updates
Email-id is invalid